HD-OPM Archive
Topics › Statins

Statins raise type 2 diabetes risk 9-12% relative, a tiny absolute effect for most people

Louis Nervegna · May 25, 2026 · ♥ 10 reactions · 4 comments · original Facebook post
StatinsInsulin resistance & diabetes
AI summary & key facts

Louis explains that in roughly 5-year RCTs, statins raise relative risk of new type 2 diabetes by 9-12% (20-36% at very high intensity). In absolute terms this is about 1 in 1000 going to 1.12 in 1000, so low-risk people see little change, while people already on the verge of diabetes may be nudged over the threshold sooner.

Statins and Diabetes
In randomized controlled trials lasting around 5 years, statins increase the relative risk of developing new-onset type 2 diabetes by about 9% to 12%.

The exact increase is dependent on the dosage and intensity of the statin, with very high-intensity regimens pushing the relative risk upward to around 20% to 36%.

Paper · Lancet Diabetes & EndocrinologyLancet Diabetes & Endocrinology articlethelancet.com ctsu.ox.ac.ukStatins can cause a small increase in blood sugar levels so people at high risk may develop diabetes soonerctsu.ox.ac.uk ▶Video · YouTube · NEJM GroupPodcast 117: Atorvastatin and new-onset diabetesStatins, according to a 2010 meta-analysis in Lancet, are associated with a slightly increased risk for new-onset type 2 diabetes. One, atorvastatin (marketed as Lipitor), was underrepresented in that analysis. Researchers, along with the manufacturer, decided to have a look at data from three trials to see whether atorvastatin also conferred that risk.…m.youtube.com Paper · Front Endocrinol (Lausanne) · 2023Statins and risk of type 2 diabetes: mechanism and clinical implications.Statins are widely used to prevent cardiovascular disease events. Cardiovascular diseases and type 2 diabetes are tightly connected since type 2 diabetes is a major risk factor for cardiovascular diseases. Additionally, cardiovascular diseases often precede the development of type 2 diabetes. These two diseases have common genetic and environmental antecedents. Statins are effective in the lowering of cardiovascular…pmc.ncbi.nlm.nih.gov

Spoiler alert: These numbers are correct. But I purposely stated them in the scariest way possible, to make a point.

What do these numbers actually mean?

Let’s walk through some examples…

If your risk of developing diabetes in the next 5 years is about 1 in 1000, then it means that your risk increases to about 1.12 in 1000.

If you are on very high intensity statins, then it increases to as much as 1.36 in 1000.

This is tiny!

But if you are right on the verge of developing diabetes anyway, then it can push you over the edge.

Say your risk of developing diabetes in the next 5 years is 1 in 2.

Now your risk goes up to 1.12 in 2, or as high as 1.36 in 2 on very high intensity dosing.

This can be enough to nudge you over the official diagnostic threshold.

The point is that people at low risk for diabetes see no appreciable increase in risk from statins.

But people at very high risk of developing diabetes can see enough of an increase in risk to push them over the edge. These people were likely going to develop diabetes anyway. The statin causes it to happen a little bit sooner than it would have otherwise.

Extensive clinical data and major meta-analyses of randomized trials backs this up:

Paper · Am J Cardiovasc Drugs · 2014Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?Statins (hydroxymethylglutaryl-coenzyme-A reductase inhibitors) are first-line agents for the management of hyperlipidemia in patients at high risk of cardiovascular (CV) events, and are the most commonly prescribed CV drugs worldwide. Although safe and generally well tolerated, there is growing evidence to suggest that statins are associated with an elevated occurrence of new-onset diabetes mellitus (DM). Recent…pmc.ncbi.nlm.nih.gov Paper · Eur Heart J · 2018Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.Conclusion: Long-term statin treatment is remarkably safe with a low risk of clinically relevant adverse effects as defined above; statin-associated muscle symptoms were discussed in a previous Consensus Statement. Importantly, the established cardiovascular benefits of statin therapy far outweigh the risk of adverse effects.pmc.ncbi.nlm.nih.gov Paper · Saudi Med J · 2016Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.Conclusion: Statin therapy can slightly increase risk of incident diabetes in subjects with hypercholesterolemia.pmc.ncbi.nlm.nih.gov Paper · Diabetes Metab J · 2013Diabetogenic effect of statins: a double-edged sword?Statins are widely prescribed cholesterol-lowering agents, which have been demonstrated to significantly reduce cardiovascular morbidity and mortality. However, recent trials have reported that statins cause worsening of hyperglycemia and increase the risk of new-onset diabetes. The association between the diabetogenic effect of statins with intensive dose and accompanying major risk factors for diabetes has been…pmc.ncbi.nlm.nih.gov Paper · Can Fam Physician · 2013Statin-induced diabetes: too sweet a deal?pmc.ncbi.nlm.nih.gov GOV.UKStatins: risk of hyperglycaemia and diabetesStatin use may be associated with a level of hyperglycaemia in some patients where formal diabetes care is appropriate.gov.uk

The bottomline is that the small increased risk of new-onset diabetes is considered clinically minor compared to the major cardiovascular benefits that statins provide.

#statindiabetesHD #statinsHD #diabetesHD

Research cited

← newer: Very low-carb diets rarely push A1C below 5 because of physiolder: Mendelian randomization shows genetically lower LDL does not →